Your browser doesn't support javascript.
loading
CD89 Is a Potent Innate Receptor for Bacteria and Mediates Host Protection from Sepsis.
de Tymowski, Christian; Heming, Nicholas; Correia, Mario D T; Abbad, Lilia; Chavarot, Nathalie; Le Stang, Marie-Bénédicte; Flament, Heloise; Bex, Julie; Boedec, Erwan; Bounaix, Carine; Soler-Torronteras, Rafael; Denamur, Erick; Galicier, Lionel; Oksenhendler, Eric; Fehling, Hans Joerg; Pinheiro da Silva, Fabiano; Benhamou, Marc; Monteiro, Renato C; Ben Mkaddem, Sanae.
Affiliation
  • de Tymowski C; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France.
  • Heming N; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France.
  • Correia MDT; Emergency Medicine Department, Medical School, University of São Paulo, São Paulo, Brazil.
  • Abbad L; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France.
  • Chavarot N; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France.
  • Le Stang MB; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France.
  • Flament H; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France.
  • Bex J; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France.
  • Boedec E; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France.
  • Bounaix C; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France.
  • Soler-Torronteras R; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France.
  • Denamur E; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; INSERM U1137, IAME, Paris, France.
  • Galicier L; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP), Paris, France; EA3518, Université Paris Diderot Paris 7, Paris, France.
  • Oksenhendler E; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP), Paris, France; EA3518, Université Paris Diderot Paris 7, Paris, France.
  • Fehling HJ; Institute of Immunology, University Clinics Ulm, Heidelberg, Germany.
  • Pinheiro da Silva F; Emergency Medicine Department, Medical School, University of São Paulo, São Paulo, Brazil.
  • Benhamou M; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France.
  • Monteiro RC; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France; Service d'Immunologie, DHU Fire, Assistance Publi
  • Ben Mkaddem S; INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France; CNRS ERL8252, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France; Inflamex Laboratory of Excellence, Paris, France. Electronic address: sanae.benmkaddem@inserm.fr.
Cell Rep ; 27(3): 762-775.e5, 2019 04 16.
Article in En | MEDLINE | ID: mdl-30995475
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptococcus pneumoniae / Receptors, Fc / Antigens, CD / Sepsis / Escherichia coli Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cell Rep Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptococcus pneumoniae / Receptors, Fc / Antigens, CD / Sepsis / Escherichia coli Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cell Rep Year: 2019 Document type: Article Affiliation country: Country of publication: